These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 4262779)

  • 1. Rat folic acid reductase activity during the perinatal period, in newborns, and after trimethoprim administration.
    Schulz R
    Naunyn Schmiedebergs Arch Pharmacol; 1972; 274(3):229-37. PubMed ID: 4262779
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition of rat folic acid reductase activity activity by trimethoprim during the later stages of gestation.
    Schulz R
    Naunyn Schmiedebergs Arch Pharmacol; 1973; 278(2):227-30. PubMed ID: 4268642
    [No Abstract]   [Full Text] [Related]  

  • 3. [Activity of the trimethoprim-sulfamethoxazole association in experimental toxoplasmosis in mice. Histochemical study].
    Cellesi C; Barberi A; Terragna A
    Boll Ist Sieroter Milan; 1973; 52(1):70-6. PubMed ID: 4714452
    [No Abstract]   [Full Text] [Related]  

  • 4. Observations on the thyroid gland in rats following the administration of sulfamethoxazole and trimethoprim.
    Swarm RL; Roberts GK; Levy AC; Hines LR
    Toxicol Appl Pharmacol; 1973 Mar; 24(3):351-63. PubMed ID: 4634184
    [No Abstract]   [Full Text] [Related]  

  • 5. [Comparative studies on the effect of antibacterial substances on inflammation and wound healing in rats].
    Lindner A; Rudas B; Selzer H
    Wien Klin Wochenschr; 1972 May; 84(18):288-91. PubMed ID: 4112433
    [No Abstract]   [Full Text] [Related]  

  • 6. Inhibition of Pneumocystis carinii, Toxoplasma gondii, and Mycobacterium avium dihydrofolate reductases by 2,4-diamino-5-[2-methoxy-5-(omega-carboxyalkyloxy)benzyl]pyrimidines: marked improvement in potency relative to trimethoprim and species selectivity relative to piritrexim.
    Rosowsky A; Forsch RA; Queener SF
    J Med Chem; 2002 Jan; 45(1):233-41. PubMed ID: 11754594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cloning and characterization of a novel trimethoprim-resistant dihydrofolate reductase from a nosocomial isolate of Staphylococcus aureus CM.S2 (IMCJ1454).
    Sekiguchi J; Tharavichitkul P; Miyoshi-Akiyama T; Chupia V; Fujino T; Araake M; Irie A; Morita K; Kuratsuji T; Kirikae T
    Antimicrob Agents Chemother; 2005 Sep; 49(9):3948-51. PubMed ID: 16127079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2,4-Diamino-6,7-dihydro-5H-cyclopenta[d]pyrimidine analogues of trimethoprim as inhibitors of Pneumocystis carinii and Toxoplasma gondii dihydrofolate reductase.
    Rosowsky A; Papoulis AT; Queener SF
    J Med Chem; 1998 Mar; 41(6):913-8. PubMed ID: 9526565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Activity of the trimethoprim-sulfamethoxazole association in experimental toxoplasmosis in mice. Histological and immuno-histological study].
    Terragna A; Cellesi C; Barberi A
    Boll Ist Sieroter Milan; 1973; 52(1):60-9. PubMed ID: 4576904
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effect of the drug combination trimethoprim-sulfamethoxazole on the intestinal flora of man in short- and long-term administration].
    Knothe H
    Arzneimittelforschung; 1973 May; 23(5):704-8. PubMed ID: 4197002
    [No Abstract]   [Full Text] [Related]  

  • 11. [Liver functional state and antibacterial activity of trimethoprim-sulfamethazole in blood, bile and urine in humans].
    Neuman M; Kazmierczak A; Charbonnier A
    Therapie; 1972; 27(6):1069-80. PubMed ID: 4661222
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of co-trimoxazole on phenylalanine metabolism.
    Stephens ME
    Lancet; 1973 Mar; 1(7802):549. PubMed ID: 4119979
    [No Abstract]   [Full Text] [Related]  

  • 13. [Pharmacodynamics and bacteriology in sulfamethoxazole-trimetoprim combination therapy].
    Bergan T
    Tidsskr Nor Laegeforen; 1972 Feb; 92(4):274-7. PubMed ID: 5016492
    [No Abstract]   [Full Text] [Related]  

  • 14. Potentiation of goitrogenic action of sulfonamide by trimethoprim.
    Kobayashi R; Harada A; Kanno Y; Yamada T
    Proc Soc Exp Biol Med; 1973 Mar; 142(3):776-80. PubMed ID: 4692008
    [No Abstract]   [Full Text] [Related]  

  • 15. In vitro screening of biochemical activity of folic acid antagonists in skin.
    McCullough JL; Weinstein GD; Hynes JB
    J Invest Dermatol; 1977 Jun; 68(6):362-5. PubMed ID: 864277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chromosomal studies in vivo and in vitro of trimethoprim and sulphamethoxazole (co-trimoxazole).
    Stevenson AC; Clarke G; Patel CR; Hughes DT
    Mutat Res; 1973 Feb; 17(2):255-60. PubMed ID: 4684402
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect ot trimethoprim on folate metabolism in human bone marrow.
    Koutts J; Van der Weyden MB; Cooper M
    Aust N Z J Med; 1973 Jun; 3(3):245-50. PubMed ID: 4517220
    [No Abstract]   [Full Text] [Related]  

  • 18. Brodimoprim, a new bacterial dihydrofolate reductase inhibitor: a minireview.
    Periti P
    J Chemother; 1995 Jun; 7(3):221-3. PubMed ID: 7562018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and biological evaluation of 2,4-diamino-6-(arylaminomethyl)pyrido[2,3-d]pyrimidines as inhibitors of Pneumocystis carinii and Toxoplasma gondii dihydrofolate reductase and as antiopportunistic infection and antitumor agents.
    Gangjee A; Adair OO; Queener SF
    J Med Chem; 2003 Nov; 46(23):5074-82. PubMed ID: 14584957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis, and antifolate activity of new analogues of piritrexim and other diaminopyrimidine dihydrofolate reductase inhibitors with omega-carboxyalkoxy or omega-carboxy-1-alkynyl substitution in the side chain.
    Chan DC; Fu H; Forsch RA; Queener SF; Rosowsky A
    J Med Chem; 2005 Jun; 48(13):4420-31. PubMed ID: 15974594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.